Alreh Caresp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-09-14. Active
30 1020 1169 0000 8402 0865 5625- 86 1020 1169 0000 8602 0834 9260
80 1090 1450 0000 0001 6050 6655
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 26, 2022 | Aid for SME access to finance — aid for start-ups | $175.9K$175,864 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
1 tender recorded as contractor, with a total value of $6,580.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Dec 30, 2025 | Zakup sprzętu w ramach realizacji Narodowej Strategii Onkologicznej pn. „Zakup sprzętu do rehabilitacji leczniczej dla pacjentów onkologicznych” w 2025 r. | $6,580$6,580 | Uniwersytecki Szpital Kliniczny w Opolu |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, 2 (two) members of the management board jointly, or a member of the management board together with a commercial proxy. If a Vice-President of the Management Board is appointed, the representation of the Company in every case requires the Vice-President of the Management Board acting jointly with another member of the management board or a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 94 | $1,269.58 | 47% | |
| 26 | $351.16 | 13% | |
Radosław Śliwerski (48) | 80 | $1,080.50 | 40% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| WP Radwansp. z o.o. | $2,306,366.78 | woodpartners.eu | ||
| Centrum Terapii Współczesnej J.M. JasnorzewskaS.K.A. | $1,145,077.18 | ctw.com.pl | ||
| Prodel R&Dsp. z o.o. | $941,906.54 | prodel.com.pl | ||
| Nanoo Printerssp. z o.o. | $150,791.60 | nanooprinters.eu | ||
| Pharmaxi Polandsp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Edurocosp. z o.o. | $126,644.58 | eduroco.pl | ||
| ConnectomeP.S.A. | $107,988.50 | connectome.name | ||
| TriomegaS.A. | $17,836.84 | triomega.pl | ||
| Ruxer-Poradniesp. z o.o. | – | ruxer-poradnie.pl | ||
| D Kosatkasp. z o.o. | – | dkosatka.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-06-16 | Share capital change (5,000.00 PLN → 10,000.00 PLN) | |
| 2018-10-09 | Entered in the register |
FAQ
Last updated: 2026-04-09